tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

StemRIM Completes Enrollment for Redasemtide Phase 2 Trial
Company AnnouncementsStemRIM Completes Enrollment for Redasemtide Phase 2 Trial
2M ago
4599
StemRIM Inc. Reports Financial Results and R&D Focus Amid Losses
PremiumCompany Announcements
StemRIM Inc. Reports Financial Results and R&D Focus Amid Losses
3M ago
4599
StemRIM Secures European Patent for Cartilage Disorder Treatment
PremiumCompany Announcements
StemRIM Secures European Patent for Cartilage Disorder Treatment
4M ago
4599
StemRIM Inc. Announces Shareholder Meeting and Capital Reduction
PremiumCompany Announcements
StemRIM Inc. Announces Shareholder Meeting and Capital Reduction
5M ago
4599
StemRIM Secures Chinese Patent for Redasemtide, Boosting Global Expansion
PremiumCompany Announcements
StemRIM Secures Chinese Patent for Redasemtide, Boosting Global Expansion
5M ago
4599
StemRIM’s Redasemtide Trial Advances with Promising Interim Results
PremiumCompany AnnouncementsStemRIM’s Redasemtide Trial Advances with Promising Interim Results
5M ago
4599
StemRIM Inc. Reports Financial Loss Amid Ongoing R&D Investments
Premium
Company Announcements
StemRIM Inc. Reports Financial Loss Amid Ongoing R&D Investments
6M ago
4599
StemRIM Amends Phase 2b Trial Protocol for Stroke Treatment
Premium
Company Announcements
StemRIM Amends Phase 2b Trial Protocol for Stroke Treatment
6M ago
4599
StemRIM Extends Research to Advance Skin Anti-Aging Solutions
PremiumCompany Announcements
StemRIM Extends Research to Advance Skin Anti-Aging Solutions
8M ago
4599
StemRIM Begins Phase 2 Trial for Cardiomyopathy Treatment
PremiumCompany Announcements
StemRIM Begins Phase 2 Trial for Cardiomyopathy Treatment
9M ago
4599
StemRIM Secures Key Role in Regenerative Medicine Project
PremiumCompany Announcements
StemRIM Secures Key Role in Regenerative Medicine Project
9M ago
4599
StemRIM Issues New Shares to Support Regenerative Medicine Goals
PremiumCompany Announcements
StemRIM Issues New Shares to Support Regenerative Medicine Goals
9M ago
4599
StemRIM Secures European Patent for Cardio Treatment
PremiumCompany AnnouncementsStemRIM Secures European Patent for Cardio Treatment
9M ago
4599
StemRIM Secures Australian Patent for Redasemtide Peptides
Premium
Company Announcements
StemRIM Secures Australian Patent for Redasemtide Peptides
9M ago
4599
StemRIM Inc. Issues New Shares to Boost Growth
Premium
Company Announcements
StemRIM Inc. Issues New Shares to Boost Growth
10M ago
4599
StemRIM Secures Japanese Patent for Regenerative Medicine
PremiumCompany Announcements
StemRIM Secures Japanese Patent for Regenerative Medicine
10M ago
4599
StemRIM Inc. Pioneers Regenerative Medicine for Global Impact
PremiumCompany Announcements
StemRIM Inc. Pioneers Regenerative Medicine for Global Impact
10M ago
4599
StemRIM Inc. to Reelect Leadership Team
PremiumCompany Announcements
StemRIM Inc. to Reelect Leadership Team
12M ago
4599
StemRIM Inc. Proposes Incentive Stock Options Plan
PremiumCompany Announcements
StemRIM Inc. Proposes Incentive Stock Options Plan
12M ago
4599
StemRIM Inc. Innovates Regenerative Medicine Frontier
PremiumCompany AnnouncementsStemRIM Inc. Innovates Regenerative Medicine Frontier
12M ago
4599
StemRIM Inc. Reports Substantial Fiscal Decline
Premium
Company Announcements
StemRIM Inc. Reports Substantial Fiscal Decline
12M ago
4599
StemRIM Inc. Reports Fiscal Year Loss, No Forecast Given
Premium
Company Announcements
StemRIM Inc. Reports Fiscal Year Loss, No Forecast Given
12M ago
4599

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >